Morning Market Gainers

shares climbed 37.63 percent to $1.64 after the company reported that it has received positive Scientific Advice from the EMA on the development path for its lead product, IMP321.

surged 35.27 percent to $27.92 after

proposed to acquire DepoMed for $29.25 per share in stock.

shares rose 10.72 percent to $2.47 after the company reaffirmed its FY15 financial targets.

climbed 8.37 percent to $8.42. Chardan Capital upgraded Himax Technologies from Sell to Buy and raised the price target from $4.00 to $13.00.

shares gained 6.55 percent to $7.36 after the company reported that it has signed a non-binding Letter of Intent for an investment and license agreement in China with Sinopharm Capital Management Co. Ltd. and Hefei Life Science & Technology Park Investments and Development Co., Ltd.

rose 6.73 percent to $39.98. GLPI raised its offer to acquire Pinnacle's real estate assets.

shares jumped 4.20 percent to $11.41 after dropping 1.26 percent on Monday.